Kawasaki Disease May Increase the Risk of Subsequent Cerebrovascular Disease

Chien-Heng Lin1,2, Jung-Nien Lai3, Inn-Chi Lee4,5

  • 1Division of Pediatric Pulmonology (C.-H.L.), China Medical University Children's Hospital, Taichung, Taiwan.

Stroke
|November 30, 2021
PubMed

Insights

Kawasaki disease (KD) significantly increases the risk of cerebrovascular disease, particularly in children under five. This finding highlights KD as a potential risk factor for stroke in pediatric populations.

Area of Science:

  • Pediatric Neurology
  • Epidemiology
  • Cardiovascular Research

Background:

  • Conflicting evidence exists regarding the link between Kawasaki disease (KD) and cerebrovascular disease.
  • Previous epidemiological studies have yielded inconsistent results on this association.

Purpose of the Study:

  • To investigate if Kawasaki disease (KD) is a risk factor for subsequent cerebrovascular disease.
  • To analyze the association between KD and cerebrovascular disease in a large-scale population-based cohort.

Main Methods:

  • A retrospective cohort study utilized Taiwan's National Health Insurance Research Database.
  • 8,467 children diagnosed with KD were compared against 33,868 matched controls without KD.
  • Follow-up data from 2000 to 2012 was analyzed for cerebrovascular disease incidence and risk.

Main Results:

  • The incidence rate of cerebrovascular disease was 3.19-fold higher in the KD cohort compared to the non-KD cohort.
  • The overall adjusted hazard ratio for cerebrovascular disease in KD patients was 3.16.
  • Children under 5 years with KD showed a significantly elevated risk (adjusted hazard ratio, 3.14).

Conclusions:

  • Kawasaki disease (KD) is associated with an increased risk of subsequent cerebrovascular disease.
  • The risk is particularly pronounced in children under five years of age diagnosed with KD.
  • This study suggests KD may be an independent risk factor for cerebrovascular events in children.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
475
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
153
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
78
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
46
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
19